Insights

Featured News

Stay up to date with the latest discoveries in structured real-world data, oncology analytics and AI-powered research.

Insights

Our Latest Insights

Stay up to date with the latest discoveries in structured real-world data, oncology analytics and AI-powered research.

Spain’s Rise as a Health Innovation Hub & What It Means for the Future of Clinical Research

Key Takeaways A New Signal from Europe Across Europe, there are renewed signs of momentum in healthcare innovation and Spain […]
Read more

Challenges and Opportunities for RWE in Clinical Hematology / Oncohematology

By Vasko Graklanov, MD, PhD, MPH This expert commentary is part of Sqilline Health’s ongoing effort to advance real-world evidence […]
Read more

How a Leading Polish Oncology Center Cut NSCLC Patient Waiting Times by Up to 40%

A leading oncology center in Poland partnered with Sqilline to tackle one of the most persistent challenges in lung cancer […]
Read more

Oncology Data Ecosystems for High-Quality Real-World Evidence

Across Europe, oncology is becoming increasingly data-driven, yet the maturity of data ecosystems still varies widely. In Romania, the field […]
Read more

Building Human-Centric Oncology Through Data and Technology

Prof. Dragan Trivanović explores how the growing complexity of oncology is reshaping the role of data, technology, and multidisciplinary collaboration […]
Read more

Rethinking Oncology Data in Spain From Fragmentation to Intelligent Care

Dr. Enrique Grande discusses how better use of clinical data can improve cancer care, support scientific progress, and strengthen evidence-based […]
Read more

From Data to Decisions in Oncology: Not a Question of AI, but Data Readiness

Key Takeaways The uncomfortable truth: oncology is data-rich, but insight-poor Across Europe, oncology generates vast amounts of clinical data every […]
Read more

Real-World Data in Rare Diseases Evidence Building Beyond Clinical Trials

Randomized clinical trials remain the cornerstone of evidence generation, but in rare diseases they often face fundamental limitations, including small […]
Read more
1 2 3